Diana Caldwell

Founded in Indianapolis in 2014, Genezen is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing services, building on the companys expansive knowledge and experience in the industry and working with the nations leading institutions. For more information, or to learn more about services offered in Genezens new cGMP facility, please visit our website: www.genezen.com

Nearly 130 angel investors across Indiana and Ohio with a growing portfolio of 60-plus growth-minded companies from across the US. At the center of Indiana’s innovation ecosystem is VisionTech Partners and VisionTech Angels. We are where inventors, entrepreneurs, investors, universities, and strategic partners converge to share, develop, fund, and launch innovative technologies. We’re entrepreneurs and angels investors ourselves. We founded VisionTech Partners as StepStone Business Partners in 2008 in Indianapolis as a privately held company focused on linking angel investors to high-potential early-stage companies. Our focus is primarily the Midwest, which is among the most vibrant innovation regions in the country. We also welcome deals with high-growth potential from across the US. We also welcome syndications.

Founded in Indianapolis in 2014, Genezen is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing services, building on the companys expansive knowledge and experience in the industry and working with the nations leading institutions. For more information, or to learn more about services offered in Genezens new cGMP facility, please visit our website: www.genezen.com

Nearly 130 angel investors across Indiana and Ohio with a growing portfolio of 60-plus growth-minded companies from across the US. At the center of Indiana’s innovation ecosystem is VisionTech Partners and VisionTech Angels. We are where inventors, entrepreneurs, investors, universities, and strategic partners converge to share, develop, fund, and launch innovative technologies. We’re entrepreneurs and angels investors ourselves. We founded VisionTech Partners as StepStone Business Partners in 2008 in Indianapolis as a privately held company focused on linking angel investors to high-potential early-stage companies. Our focus is primarily the Midwest, which is among the most vibrant innovation regions in the country. We also welcome deals with high-growth potential from across the US. We also welcome syndications.

Pearl Pathways is a comprehensive life science regulatory, quality compliance, and clinical services consulting company providing strategic guidance and project-based support for emerging to mid-size biopharmaceutical, medical device, and diagnostic companies. As the recognized trusted advisor and preferred partner for enabling innovative and expedited life science product development, our nimble and flexible team of experts provides custom solutions that help our clients deliver vital products to market. Our consultants collaboratively leverage decades of clinical, scientific, industry, FDA and global regulatory authority experience to help our clients successfully navigate a highly complex regulatory environment while balancing risk, speed to market, and cost to achieve their business goals. Pearl Pathways supports all aspects of human research through its full-service central independent review board, Pearl IRB. Founded in 2010, Pearl Pathways is headquartered in Indianapolis, IN and is proud to be a certified Women’s Business Enterprise.